Safety, escort for Daye peak
Release time:
2020-08-14
Safety, Escorting Daye Peak
9# In mid-May, the Group Company organized Jinhua Enterprise Safety Officer to go to Daye Peak Cement Company for safety inspection and exchange. As the saying goes, "every line is like a mountain". As an employee of a pharmaceutical company, he is in a refined atmosphere all day long. When the behemoth cement tank stands in front of him, he suddenly shocked.
According to the cement production process, we first came to the limestone mine at the peak of Daye. Several stretches of hilltop have been stripped of vegetation, and dark brown rocks are exposed, winding down layer by layer. Several large trucks shuttled back and forth, pouring limestone into the conveyor belt entrance. We have some doubts, why not according to the section of mining? Daye peak colleagues said, limestone ore is layered distribution, each layer of the composition content is different, fully mixed can be used as raw materials, to produce qualified products.
After a long conveyor belt, limestone is transported from the mine to a large "tent" in the factory area-the homogenization warehouse, and then ground and crushed together with clay and page stone to form the so-called "raw material". The raw material is heated to a certain temperature by the five-stage cyclone preheater, enters the decomposer, and then goes to the huge rotary kiln. After being baptized by the high temperature of 1000 , the raw material is slowly fused and gradually becomes clinker. In such a production process, all equipment is switched on and off by the central control.
Cement products are measured in "tons", while pharmaceuticals are measured in "grams. We joked that if the pharmaceutical industry is Jiangnan boudoir, cement is the big fellow in the north. However, this "big fellow in the north" has brought a little bit of delicacy in its crudeness-in the "boiler inspection" board, it is carefully marked with "medium and high hazard source", "pipeline scald" and "risk degree: medium". accident cases are also pasted in several places prone to potential safety hazards. in the seemingly extensive production mode, safety management is like spring breeze and drizzle, which is carefully integrated into it.
According to introduction, after years of unremitting efforts, Daye Peak has established a relatively perfect management system, passed the second level of safety production standardization, and is currently preparing to upgrade to the first level standard from perfecting the safety system, improving employees' safety awareness, investigating hidden dangers in teams and groups, paying close attention to the daily management of teams and groups, from the identification of hazard sources, the operation of fixed details to the hierarchical control of safety risks. Dust, noise, and exhaust gas emissions, which are common problems in cement production enterprises, have also been basically rectified in Daye Peak, and environmental protection work has reached a new level.
After the inspection, the members of the inspection team expressed their opinions one after another, affirming Daye's achievements in safety and environmental protection. At the same time, they also put forward rectification opinions on some existing defects, such as the receipt and signature of protective articles to individuals in the department, reflective strips should be posted on the guiding iron link, etc. Perhaps, as everyone said, some defects will be ignored after a long time, checking each other is the best way to improve.
In just one day of interactive communication, we "pick" Daye Peak's safety and environmental protection work from the perspective of "bystanders", and we have also learned a lot of relevant management experience. Of course, what is more important is to further feel the charm of spike cement. Daye Peak, a large ship loaded with cement, is sailing ahead under the protection of safety and environmental protection... (Peach Death)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31